ImmunoGen Inc (IMGN)

[skitahoe]

The recent gains IMGN made since it's most recent lows shouldn't put people into margin calls unless they've been staying right on the edge of what was permissible. Once it's above $7 again I suspect they'll lower the requirement and allow maximum margin for those who wish to do so. Depending on what's said Wednesday at the JPM Healthcare Conference, $7 or more may come very quickly. I don't know that they can announce unblinding the Phase 3 Trial at that time, but if not, I think they can estimate how close it is. Clearly the results of the Phase 3 will either send the stock to new highs, or new lows, I believe it will be highs.

Gary